Gene:
CUGBP2
CUG triplet repeat, RNA binding protein 2

PharmGKB contains no dosing guidelines for this gene. To report known dosing guidelines, or if you are interested in developing guidelines, click here.

PharmGKB contains no drug labels with pharmacogenomic information for this gene. To report a drug label with PGx, click here.

PharmGKB contains no clinical annotations for this gene. To report clinical variants, click here.

PharmGKB contains no genetic tests for this gene. To report genetic tests, click here.

Overview

Alternate Names:  CUG triplet repeat, RNA-binding protein 2; CUG triplet repeat,RNA-binding protein 2; ELAV-type RNA-binding protein 3; OTTHUMP00000019076; OTTHUMP00000019077; elav-type RNA-binding protein; neuroblastoma apoptosis-related RNA-binding protein
Alternate Symbols:  BRUNOL3; ETR-3; ETR3; Etr-3; NAPOR; NAPOR-2
PharmGKB Accession Id: PA27046

Details

Cytogenetic Location: chr10 : p14 - p14
GP mRNA Boundary†: chr10 : 11047259 - 11378674
GP Gene Boundary†: chr10 : 11037259 - 11381674
Strand: plus
Product Name: No data available
† The mRNA boundaries are calculated using the gene's default feature set from NCBI, mapped onto the UCSC Golden Path. PharmGKB sets gene boundaries by expanding the mRNA boundaries by no less than 10,000 bases upstream (5') and 3,000 bases downstream (3') to allow for potential regulatory regions.

Publications related to CUGBP2: 1

No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Growth factor regulation of prostaglandin-endoperoxide synthase 2 (Ptgs2) expression in colonic mesenchymal stem cells. The Journal of biological chemistry. 2010. Walker Monica R, et al. [Article:20018844@PubMed]
PharmGKB® is a registered trademark of HHS and is financially supported by NIH/NIGMS. It is managed at Stanford University (R24 GM61374).
©2001-2012 PharmGKB.